This review summarizes the current landscape of ADC development, focusing on target selection and adverse impacts. It will guide future research to optimize the efficacy and safety of ADCs. ADCs are a ...

CAMBRIDGE, Mass., April 22, 2026 — Insilico Medicine (“Insilico”, 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, recently published a comprehensive ...

Target is moving full steam ahead on a turnaround plan with the goal to reverse declining sales and traffic numbers — and technology is playing a key role. Current COO and incoming CEO Michael ...